Blood test markers to assess acute pancreatitis severity and outcomes
Part of Digestive system clinical trials.
This study looks at whether simple blood test results can help doctors understand how severe your acute pancreatitis is and how well you might recover. By tracking these blood markers, doctors hope to better predict outcomes for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with acute pancreatitis (sudden pancreas inflammation).
- You must have been treated at Assiut University Hospital between January 2019 and March 2025.
- You must not have chronic kidney disease.
- You must not be pregnant.
- You must not have a history of cancer, current acute infection, or blood diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a simple blood test measuring two substances, called the neutrophil–creatinine index, can help predict how severe your pancreatitis is and how you will recover. If you have acute pancreatitis, this could help doctors understand your condition better.
This study looks at whether simple health checks at the hospital can help predict how older adults with acute pancreatitis will recover. It may help doctors provide better care and information to you or your loved one.
This study looks at specific blood markers during an acute pancreatitis episode to better understand the condition. It may help improve treatment for future patients.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This study looks at two simple blood markers (C-reactive protein and albumin) to see if they can help predict kidney damage in people with acute pancreatitis. If you join, you might help doctors find kidney problems earlier and improve care for future patients.
This trial collects blood samples from people with infected pancreatic necrosis to find patterns that help diagnose the condition. The goal is to reduce the need for invasive tests and start treatment faster.
Hear when a new Acute Pancreatitis (AP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.